Use access key #2 to skip to page content.
$45.80 1.67 (3.78%)
7/3/2008 1:00 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

View All Commentary (AZN)

Recs

1

Avatar marionvb (91.19) Submitted: 4/06/07 4:50 PM : Underperform Start Price: $51.67 AZN Score: -1.32

They may need some Levitra as some of their drugs go off patent.

Report this Post Replies: 1 | Reply

Avatar tommycarstensen (92.52) Submitted: 2/23/08 8:24 AM

Recs: 0 | Rec This

What is your oppinion about the acquisition of MedImmune? I personally think $15.6 bln was a lot to pay for revenue of less than $2 bln per year.

Report this Post Reply

Featured Broker Partners